Roivant Sciences Ltd. (ROIV)
NASDAQ: ROIV · Real-Time Price · USD
11.55
-0.10 (-0.86%)
At close: Aug 7, 2025, 4:00 PM
11.08
-0.47 (-4.07%)
After-hours: Aug 7, 2025, 7:09 PM EDT
Accolade Market Cap
Roivant Sciences has a market cap or net worth of $7.88 billion as of August 7, 2025. Its market cap has decreased by -3.08% in one year.
Market Cap
7.88B
Enterprise Value
3.10B
1-Year Change
-3.08%
Ranking
Category
Stock Price
$11.55
Market Cap Chart
Since December 8, 2020, Roivant Sciences's market cap has increased from $533.38M to $7.88B, an increase of 1,377.96%. That is a compound annual growth rate of 78.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2025 | 7.88B | -8.46% |
| Dec 31, 2024 | 8.61B | -4.61% |
| Dec 29, 2023 | 9.03B | 55.76% |
| Dec 30, 2022 | 5.80B | -18.13% |
| Dec 31, 2021 | 7.08B | 1,257.32% |
| Dec 31, 2020 | 521.58M | -2.21% |
| Dec 8, 2020 | 533.38M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 575.32B |
| Johnson & Johnson | 413.10B |
| AbbVie | 351.30B |
| Abbott Laboratories | 229.85B |
| AstraZeneca | 227.78B |
| Novartis AG | 223.01B |
| UnitedHealth Group | 221.95B |
| Novo Nordisk | 213.92B |